⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19339583 | 1.00 | — | — | |
| SCHEMBL19364845 | 0.96 | — | — | |
| SCHEMBL21898095 | 0.92 | — | — | |
| SCHEMBL20055067 | 0.92 | — | — | |
| SCHEMBL18462894 | 0.78 | HDAC6 (0.30) | — | |
| SCHEMBL21554703 | 0.76 | DPP4 (0.32) | — | |
| SCHEMBL22943752 | 0.76 | HDAC6 (0.32) | — | |
| SCHEMBL22944864 | 0.76 | HDAC6 (0.32) | — | |
| SCHEMBL24754130 | 0.76 | — | — | |
| SCHEMBL26724058 | 0.76 | DPP4 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11738013-B2 | Methods for treating hepatitis B virus infections using NS5A, NS5B or NS3 inhibitors | GILEAD SCIENCES, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-20220117952-A1 | METHODS FOR TREATING HEPATITIS B VIRUS INFECTIONS USING NS5A, NS5B OR NS3 INHIBITORS | GILEAD SCIENCES, INC. | 2022-04-21 | — | — | US | disclosed |